Growth Technologies Inc (fka GRWT)

[Split-the-Aces]

My prior post on USSE. I'm still trying to figure this technology out:

U.S. Sustainable Energy Corporation and Nanobac Pharmaceuticals, Inc. Investigate Nanobacteria Link to Energy Production

Tuesday April 18, 2006 2:13 pm ET

http://biz.yahoo.com/iw/060418/0123621.html

John Stanton is the Chairman of Nanobac and of course is or was connected with USSE. The release goes through the initial plan to couple technology through CYBR, and that apparently fell through with the reverse merger done with LFZA:

"The Company's technologies will include the rights to the certain patents and intellectual property rights currently contained in EarthFirst Technologies, Inc. (OTC BB:EFTI.OB - News). Under EarthFirst's previously announced planned merger with Cast-Crete Corporation, EarthFirst/Cast-Crete will become the co-proponent of the Plan of Reorganization of CyberCare, Inc. ("CyberCare") (Other OTC:CYBR.PK - News). After the merger with Cast-Crete and CyberCare's emergence from reorganization, EarthFirst/Cast-Crete intend to combine the existing energy technologies with CyberCare's technology assets. The surviving entity will be known as U.S. Sustainable Energy Corporation.

Nanobac has previously announced published research that demonstrated the role nanobacteria play in the production of electricity. A fuel cell was used to enrich a microbial consortium generating electricity. Nanobacteria-like particles were present on the biofilm surface.

See: Water Environment & Remediation Research Center, Korea Institute of Science and Technology, 39-1 Hawolgok, Sungpook, 136-791, Seoul, Korea. [e-mail]


A fuel cell was used to enrich a microbial consortium generating electricity, using organic wastewater as the fuel. Within 30 days of enrichment the maximum current of 0.2 mA was generated with a resistance of 1 kOhms. Current generation was coupled to a fall in chemical oxygen demand from over 1,700 mg l(-1) down to 50 mg l(-1). Denaturing gradient gel electrophoresis showed a different microbial population in the enriched electrode from that in the sludge used as the inoculum. Electron microscopic observation showed a biofilm on the electrode surface and microbial clumps. Nanobacteria-like particles were present on the biofilm surface. Metabolic inhibitors and electron acceptors inhibited the current generation. 16S ribosomal RNA gene analysis showed a diverse bacterial population in the enrichment culture. These findings demonstrate that an electricity-generating microbial consortium can be enriched using a fuel cell and that the electrochemical activity is a form of anaerobic electron transfer.


PMID: 12908088 [PubMed - indexed for MEDLINE]

John Stanton, Chairman of both Nanobac and U.S. Sustainable, stated that Nanobac's continuing research with the National Aeronautics and Space Administration ("NASA") suggests potential energy, as well as healthcare, implications of nanobacteria. Our goal is to discover, or invent, and then commercialize technologies that enhance our way of life through sustainable energy development that "does no harm" to our health, or environment."

The only published patent applications I could find are assigned to Nanobac Pharmaceuticals, and include the following:

PUB. APP. NO. Title
1 20060083727 Methods and compositions for the treatment of diseases characterized by calcification and/or plaque formation

2 20060069069 Methods and compositions for the administration of calcium chelators, bisphosponates and/or citrate compounds and their pharmaceutical uses

3 20060069068 Methods and compositions for the treatment of diseases characterized by pathological calcification

Although these patent applications deal with nanobacteria and a claimed method for preventing and treating diseases caused by pathological calcification, the technology also has claimed benefit in energy.

A read of those patent applications themselves is incredible and could provide a huge breakthrough in treating calcification-induced diseases, such as Arteriosclerosis, Atherosclerosis, Coronary Heart Disease, Chronic Heart Failure, Valve Calcifications, Arterial Aneurysms, Calcific Aortic Stenosis, Transient Cerebral Ischemia, Stroke, Peripheral Vascular Disease, Vascular Thrombosis, Dental Plaque, Gum Disease (dental pulp stones), Salivary Gland Stones, Chronic Infection Syndromes such as Chronic Fatigue Syndrome, etc., etc., etc., etc.

The study of the nanobacteria was apparently important to NASA because of the effects on astronauts due to microgravity environments. It was determined through study between NASA and Nanobac that nanobacteria growth accelerated in microgravity environments. As nanobacteria grow faster in microgravity it provided a possible explanation for the increase in kidney stone formation in astronauts during space flights.

See: Ciftcioglu, N., R. S. Haddad, D. C. Golden, D. R. Morrison, D. S. McKay. 2005. A potential cause of kidney stone formation during space flights: Enhanced growth of nanobacteria in microgravity. Kidney International. 67: 483-491. www.ncbi.nlm.nih.gov

Statements were then made that USSE and Nanobac were investigating whether nanobacterial growth actually enhanced bio-fuel productivity.

"It has been substantiated that calcific diseases propagate in microgravity because nanobacteria growth in that environment is accelerated. We are specifically investigating whether or not the vacuum created in the biofuel production process might accelerate nanobacteria growth, thus enhancing biofuel productivity."

This is further confirmed from the news released on our iHub board above:

"During the conversion process the beans and/or corn are loaded in one side of the reactor, enter into the vacuum/reaction chamber, and the gas, liquid, and solids are separated at the end. The gas is similar to a natural gas but higher in energy density as well. It also contains a significant portion of hydrogen which helps engines burn the hydrocarbons cleaner."

Thus there is a relation between nanobacteria and the enhanced fuel production by and through research of Nanobac and USSE. It relates to the vacuum used in the process to increase fuel production.

In the interests of caution, I have also bought into Nanobac Pharmaceuticals, NNBC.OB, as they are tied in, at least through nanobacteria research investigated by USSE. Of course I suggest that you do your own DD before buying anything.

In addition, NNBC have made some incredible findings that are listed in the above published patent applications. They will be having a conference call by none other than our own mystery man, John Stanton on November 16, 2006.

Press Release Source: Nanobac Pharmaceuticals Inc.

Nanobac Pharmaceuticals Inc. Announces Investor Conference Call, Hosted by John Stanton, Chairman

http://biz.yahoo.com/bw/061109/20061109005865.html?.v=1

Like I said this research maybe old hat for many of the crusties on the board, but I think the nanobacteria technology is revolutionary, not only from an energy standpoint but also from a health science application. Good luck to all!